Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600–Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials

IMPORTANCE: Prognostic models may provide insight into clinical trial results and inform the clinical management of patients with BRAF V600–mutated metastatic melanoma. OBJECTIVE: To identify subgroups with distinct survival outcomes based on clinical and genomic characteristics and to assess surviv...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Oncol
Autores principales: Hauschild, Axel, Larkin, James, Ribas, Antoni, Dréno, Brigitte, Flaherty, Keith T., Ascierto, Paolo A., Lewis, Karl D., McKenna, Edward, Zhu, Qian, Mun, Yong, McArthur, Grant A.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2018
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233771/
https://ncbi.nlm.nih.gov/pubmed/30073321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.2668
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares